Wegovy Maker Novo Nordisk’s Oral Diabetes Pill Cuts Heart Attacks, Stroke Events By 14%

On Monday, Novo Nordisk A/S (NYSE:NVO) released the headline results from the SOUL Phase 3 cardiovascular outcomes trial. Last year, Novo Nordisk’s subcutaneous once-weekly (injectable) semaglutide 2.4 mg, available as Wegovy, showed a 20% reduction in MACE compared to placebo.  The SOUL trial compared oral semaglutide to placebo as an adjunct to the standard of […]

Analysts Give Their Take On 3 Financials Stocks Delivering High-Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. Benzinga readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings page. Traders can sort through […]

Elon Musk Donates $75M To Support Donald Trump’s Presidential Campaign

Tesla CEO Elon Musk has made a significant financial contribution of nearly $75 million to support Donald Trump‘s bid for the presidency. This donation was made in the third quarter to America Pac, Musk’s political action committee, as revealed by a federal filing on Tuesday. What Happened: The committee has already expended over $96 million […]

Why is Longboard Pharmaceuticals Higher: Here Are 20 Stocks Moving Monday

Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) rose sharply in today’s pre-market trading. Lundbeck agreed to acquire Longboard Pharmaceuticals in a transaction valued at approximately $2.6 billion equity value. Longboard Pharmaceuticals shares jumped 46.8% to $57.13 in the pre-market trading session. Here are some other stocks moving in pre-market trading. Gainers Inventiva S.A. (NYSE:IVA) rose 86.2% […]

This Amazon Analyst Begins Coverage On A Bullish Note; Here Are Top 5

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Pivotal Research analyst Jeffrey Wlodarczak initiated coverage on Amazon.com, Inc. (NASDAQ:AMZN) with a Buy rating and announced a price target of $260. Amazon shares gained […]

Major Tesla Supplier Arcadium Lithium Jumps Over 30%

Rio Tinto PLC ADR (NYSE:RIO) has announced a definitive agreement to acquire Arcadium Lithium plc (NYSE:ALTM) in an all-cash deal valued at $6.7 billion. What Happened: As per the press release on Wednesday, the acquisition price of $5.85 per share represents a 90% premium over Arcadium’s closing price on Oct. 4. According to Benzinga Pro, […]

CrowdStrike, Deckers, Ares Management And A Big Bank Stock On CNBC’s ‘Final Trades’

On CNBC’s “Halftime Report Final Trades,” Rob Sechan of NewEdge Wealth named Deckers Outdoor Corporation (NYSE:DECK) because of jobs report. On Sept. 13, Deckers Brands announced stockholder approval of six-for-one forward stock split and proportionate increase in authorized common stock. Jim Lebenthal of Cerity Partners picked Citigroup Inc. (NYSE:C). On Sept. 26, Citigroup inked an […]

JP Morgan Takes Stake In Australian Casino

JP Morgan Chase & Co. (NYSE:JPM) shares are trading higher on Friday. On October 1, 2024, the company became a substantial shareholder in The Star Entertainment Group Limited, acquiring 156.99 million ordinary shares, representing 5.47% voting power. Star Entertainment is an Australian casino operator. The company has been in troubled waters due to liquidity issues, […]

Newsletter

Wegovy Maker Novo Nordisk’s Oral Diabetes Pill Cuts Heart Attacks, Stroke Events By 14%

October 21, 2024

On Monday, Novo Nordisk A/S (NYSE:NVO) released the headline results from the SOUL Phase 3 cardiovascular outcomes trial. Last year, Novo Nordisk’s subcutaneous once-weekly (injectable) semaglutide 2.4 mg, available as Wegovy, showed a 20% reduction in MACE compared to placebo.  The SOUL trial compared oral semaglutide to placebo as an adjunct to the standard of […]
Read More